Replies to post #143615 on Biotech Values

[poorgradstudent]

OT:

Dr. Olson came to talk here last year.

Their labwork is impressive. Very impressive. My personal hunch / bias is that this isn't going to do that much in the clinic. But I guess we'll see :-)

Here is something I'm a little more hopeful about:

http://www.trevenainc.com/pipeline.php

I think the biased ligand concept is attractive.

[DewDiligence]

Can anyone recall the products that GILD sells from the Myogen buyout?

Letairis.